345 related articles for article (PubMed ID: 30194081)
1. Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.
Yueh TC; Hung YW; Shih TC; Wu CN; Wang SC; Lai YL; Hsu SW; Wu MH; Fu CK; Wang YC; Ke TW; Chang WS; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(5):405-411. PubMed ID: 30194081
[TBL] [Abstract][Full Text] [Related]
2. The Contribution of
Yueh TC; Wu CN; Hung YW; Chang WS; Fu CK; Pei JS; Wu MH; Lai YL; Lee YM; Yen ST; Li HT; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(3):207-212. PubMed ID: 29695403
[TBL] [Abstract][Full Text] [Related]
3. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
Abderrahmane R; Louhibi L; Moghtit FZ; Boubekeur A; Benseddik K; Boudjema A; Benrrahal F; Aberkane M; Fodil M; Saidi-Mehtar N
Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
[TBL] [Abstract][Full Text] [Related]
4. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
Tuna G; Küçükhüseyin O; Arıkan S; Kaytan Sağlam E; Güler E; Cacına C; Oztop O; Turan S; Korkmaz G; Yaylım I
DNA Cell Biol; 2013 Jul; 32(7):400-8. PubMed ID: 23777425
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
Wu MH; Hung YW; Gong CL; Chao CC; Yueh TC; Wang SC; Lai YL; Hsu SW; Fu CK; Wang YC; Ke TW; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2019 Jun; 39(6):2791-2797. PubMed ID: 31177115
[TBL] [Abstract][Full Text] [Related]
6. The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
Yueh TC; Chou AK; Gong CL; Fu CK; Pei JS; Wu MH; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Bau DT
Anticancer Res; 2017 May; 37(5):2307-2313. PubMed ID: 28476796
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.
Zhang X; Pageon L; Post SM
Oncogene; 2015 Aug; 34(33):4412-20. PubMed ID: 25435368
[TBL] [Abstract][Full Text] [Related]
8. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
9. MDM2 SNP309 polymorphism is associated with colorectal cancer risk.
Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M
Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837
[TBL] [Abstract][Full Text] [Related]
10. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
[TBL] [Abstract][Full Text] [Related]
11. Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk.
Lin YC; Chang WS; Shen TC; Li HT; Li CH; Hsiau YC; Wang YC; Wu CN; Gong CL; Wang ZH; Tsai CW; Hsia TC; Bau DT
In Vivo; 2020; 34(3):1047-1052. PubMed ID: 32354891
[TBL] [Abstract][Full Text] [Related]
12. Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer.
Sun YF; Leu JD; Chen SM; Lin IF; Lee YJ
BMC Cancer; 2009 Jan; 9():13. PubMed ID: 19144119
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Lin KM; Yang MD; Tsai CW; Chang WS; Hsiao CL; Jeng LB; Yueh TC; Lee MC; Bau DT
Anticancer Res; 2018 Apr; 38(4):2001-2006. PubMed ID: 29599316
[TBL] [Abstract][Full Text] [Related]
14. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
15. MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.
Xiao FK; Guo S; Yang F; Zhao LS; Wang LD
J Gene Med; 2019 May; 21(5):e3086. PubMed ID: 30861607
[TBL] [Abstract][Full Text] [Related]
16. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
[TBL] [Abstract][Full Text] [Related]
17. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
[TBL] [Abstract][Full Text] [Related]
18. MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Int J Cancer; 2007 Feb; 120(3):563-5. PubMed ID: 17096342
[TBL] [Abstract][Full Text] [Related]
19. Association of
Hung YC; Chang WS; Chou AK; Pei JS; Yang MD; Yang HR; Yang TM; Wang YC; Hsiau YC; Chen CP; Chen CC; Yu CC; Tsai CW; Bau DT
Anticancer Res; 2020 Mar; 40(3):1297-1306. PubMed ID: 32132026
[TBL] [Abstract][Full Text] [Related]
20. Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancer.
Hitzenbichler F; Stoehr CG; Rogenhofer M; Wieland WF; Ruemmele P; Hartmann A; Stoehr R
Pathobiology; 2014; 81(2):53-9. PubMed ID: 24217660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
